News Posts List
Seventh annual 'Lift for Life' set for July 10
05/22/2009
University Park, Pa. Over its initial six years, the Penn State Lift For Life has grown tremendously. Last year, more than 90 Nittany Lion football student-athletes tested their strength and endurance in an 11-event strength and conditioning challenge that raised more than $70,000 for the Kidney Cancer Association.
Phase II Study of Metastatic Cancer
05/21/2009
Patients with melanoma or renal cell cancer must have previously received high-dose aldesleukin AND have either progressive or recurrent disease.
Pfizer announces program to help unemployed
05/18/2009
Pfizer Inc has announced an innovative patient assistance program to help eligible unemployed Americans and their families who have lost their health insurance maintain access to their Pfizer medicines at no cost. Over 70 Pfizer primary care medicines are available through the program. For more information, call 1-866-706-2400.
Proteolix to Present Carfilzomib Clinical Data
05/18/2009
Proteolix to Present Carfilzomib Clinical Data During the 2009 ASCO Annual Meeting. Results from Phase 2 Clinical Trials of Carfilzomib in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Featured in Oral Presentations.
Actress Denise Richards raises awareness of kidney cancer
05/18/2009
"They said, 'Will you sing?' So I said, 'Yes, because it's for a good cause and we want to raise awareness about kidney cancer.
CT Scans Increase Cancer Risk
05/16/2009
Physicians should review a patient's CT imaging history and cumulative radiation dose when considering whether to perform another CT exam.
Universal coverage is impossible without coercion
05/15/2009
Tens of millions of Americans would lose their current health insurance and could also lose their current doctors, President Obama's reassurances notwithstanding. Since there aren't enough Americans earning more than $250,000 to finance the estimated $1.7 trillion price tag, reform would mean higher taxes for the middle class.
Final Phase 2 Results for IL-21
05/15/2009
Favorable Response Rate in Patients Who Have Failed Prior Therapy.
Pazopanib prolonged progression- free survival 5 months
05/15/2009
Phase III clinical trial results show promise.
Adenovirus for kidney cancer treatment
05/15/2009
These results suggest that a targeted, antiangiogenic, oncolytic adenovirus might be a valuable agent for testing in kidney cancer patients.
News Feed